Omaxe Limited
Momentum (95/100) does the heavy lifting; financial trend (0/100) is the drag.
ExpensiveSolvency riskOmaxe Limited earns a Sell from StocksWizard, with a blended score of 38/100. We put fair value near ₹192.75; at ₹123.98 that leaves roughly 55% upside, so the stock screens undervalued by 55%. The price is about 9% below its 52-week high of ₹136.38 and 93% above the low of ₹64.09. Financial health scores 0/100, in the distress band on the Altman Z-score, with a Piotroski F-score of 4/9. It clears 4 of 10 investability checks, with durability 5, valuation 15 and momentum 95 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹154.2. Low-confidence estimate — limited data.
1-year price
EOD · 2026-09-1452-week range
-9.09% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell38Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- No data: ROE above 15%
- No data: Low debt (D/E < 0.5)
- Fail: Positive free cash flow
- Fail: Revenue growth > 10%: -36%
- No data: Earnings growing
- Fail: Net margin ≥ 10%: -55.6%
- Fail: Current ratio > 1.5: 0.97
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z -0.02
- Fail: Piotroski ≥ 7: 4/9
Annual financials
Shareholding
- Promoter77.2%
- Institutions4.2%
- Public & other18.6%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Trades ~56% below our estimated fair value.
Bear case
Threats
- Rich valuation versus sector peers.
- Balance-sheet stress — Altman Z -0.02.
About Omaxe Limited
Omaxe Limited is an Indian real estate developer operating across residential, commercial, retail, and integrated township projects. Its portfolio encompasses group housing, SCOs, shopping malls, hotels, and office spaces. The company changed its name from Omaxe Construction Limited in June 2006.
Omaxe Limited — frequently asked questions
Is Omaxe Limited a buy, hold or sell?
StocksWizard currently rates Omaxe Limited (OMAXE) a Sell, based on a blended score of 38/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Omaxe Limited's fair value?
Our blended DCF and relative-valuation model estimates Omaxe Limited's fair value at about ₹192.75, versus a current price of ₹123.98 — roughly 55% upside. On that basis the stock looks undervalued by 55%.
Is Omaxe Limited financially healthy?
Omaxe Limited scores 0/100 on our financial-health model, placing it in the distress band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Omaxe Limited's share price performed?
Omaxe Limited is up 58% over three months, and last traded at ₹123.98. Past performance doesn't predict future returns.
More in Real Estate
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.